The cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritis.
about
Pain management for rheumatoid arthritis and cardiovascular or renal comorbidityEncouraging physician appropriate prescribing of non-steroidal anti-inflammatory therapies: protocol of a randomized controlled trial [ISRCTN43532635].An economic model of long-term use of celecoxib in patients with osteoarthritisA comparison of cost effectiveness using data from randomized trials or actual clinical practice: selective cox-2 inhibitors as an exampleCost-effectiveness analyses of osteoarthritis oral therapies: a systematic review.Accounting for the increase in NSAID expenditure: substitution or leakage?Lifetime medical costs of knee osteoarthritis management in the United States: impact of extending indications for total knee arthroplasty.Gastroprotective strategies among NSAID users: guidelines for appropriate use in chronic illnessModeling rheumatoid arthritis using different techniques - a review of model construction and results.Adoption of celecoxib and rofecoxib: a nationwide database study.Cost-effectiveness of nonsteroidal anti-inflammatory drugs and opioids in the treatment of knee osteoarthritis in older patients with multiple comorbidities.Cost-effectiveness analysis for joint pain treatment in patients with osteoarthritis treated at the Instituto Mexicano del Seguro Social (IMSS): Comparison of nonsteroidal anti-inflammatory drugs (NSAIDs) vs. cyclooxygenase-2 selective inhibitors.Economic outcomes for celecoxib: a systematic review of pharmacoeconomic studies.Cost-utility analysis of duloxetine in osteoarthritis: a US private payer perspective.Economic evaluation of nonsteroidal anti-inflammatory drug strategies in rheumatoid arthritis.A randomized, multicentre, double-blind, parallel-group study to assess the adverse event-related discontinuation rate with celecoxib and diclofenac in elderly patients with osteoarthritis.Economic evaluation of etoricoxib versus non-selective NSAIDs in the treatment of osteoarthritis and rheumatoid arthritis patients in the UK.Medical and pharmacy expenditures after implementation of a cyclooxygenase-2 inhibitor prior authorization program.Physicians' approaches to the use of gastroprotective strategies in low-risk non-steroidal anti-inflammatory drug users.Modelling the complete continuum of care using system dynamics: the case of osteoarthritis in Alberta
P2860
Q24235971-CEEE0DB5-CB22-4751-901D-C140E0C35B53Q24806495-86F52811-0247-4A04-B6FC-C4152CAB6122Q28218005-295407A2-A47E-4F61-9043-03A5B68A1DF2Q28472098-05D1B0BD-F3D2-45E4-ABBF-F62CC818200BQ34384075-B76D1A91-6BF5-4BC6-907B-F7E21EB70DBFQ34768089-14590A6A-6033-46D3-9378-6FCFD1263CFEQ35576022-371C807E-4C3F-4D26-8A25-0645AF283E38Q35613265-907BCACA-0DB8-44D8-9B1C-B1360D8F02AAQ35851012-98997207-FF90-4D70-B5FC-528DD7A36B5AQ36089445-CDE4AB58-556C-44E6-B5D2-950AF8E49D5AQ36600338-EA2A1DB6-ADB9-4637-851F-2213A634D373Q37061561-B05ABD3F-32DB-421C-A0DD-96D1A4A8E9E8Q38042714-CCEC957A-9DFD-4816-89D1-3075875C6A3EQ45347178-FEDBADD3-81DC-442B-B6A1-9CBC58914E7AQ46051343-1C2904DC-AECA-4B54-90C7-AA0BB1BEA6AFQ46150327-2F16C6DE-88BC-4C07-A27C-53BBC36AF266Q46574420-FDBA38E8-42E1-480B-9974-E67D1716275FQ46592047-82DCD249-7FAA-4DC6-AA01-505B7CF873A0Q50780625-F6C749DE-5872-4498-9DE2-C30DB74B7002Q57759101-1C6E51C0-8846-4D18-97C2-41CB2AB73F89
P2860
The cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritis.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
The cost effectiveness of rofe ...... ritis or rheumatoid arthritis.
@en
The cost effectiveness of rofe ...... ritis or rheumatoid arthritis.
@nl
type
label
The cost effectiveness of rofe ...... ritis or rheumatoid arthritis.
@en
The cost effectiveness of rofe ...... ritis or rheumatoid arthritis.
@nl
prefLabel
The cost effectiveness of rofe ...... ritis or rheumatoid arthritis.
@en
The cost effectiveness of rofe ...... ritis or rheumatoid arthritis.
@nl
P356
P1476
The cost effectiveness of rofe ...... ritis or rheumatoid arthritis.
@en
P2093
Andreas Maetzel
Gary Naglie
P304
P356
10.1002/ART.11121
P50
P577
2003-06-01T00:00:00Z